Hard to say. I think the branch itself is too immature to have as much clout as it does, but we'd make a lot of progress if they'd start listening to their pat

Hard to say. I think the branch itself is too immature to have as much clout as it does, but we'd make a lot of progress if they'd start listening to their patients more than they listen to their drug reps.